T. Rowe Price Investment Management, Inc. - 28 Feb 2026 SCHEDULE 13G Report for APOGEE THERAPEUTICS INC COMMON STOCK (APGE)

Filing Manager: T. Rowe Price Investment Management, Inc.
Reporting Manager: T. Rowe Price Investment Management, Inc.
Security: APOGEE THERAPEUTICS INC COMMON STOCK
Symbol: APGE
Shares outstanding: 54,989,619 shares
Disclosed Ownership: 6,213,827 shares
Ownership: 11%
Form type: SCHEDULE 13G
Filing time: 06 Mar 2026, 12:57:46 UTC
Date of event: 28 Feb 2026
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
T. Rowe Price Investment Management, Inc.	11%	6,213,827	5,879,389	0	Ellen York	Vice President